[Translation] Phase I/II clinical study to evaluate the safety, tolerability, pharmacokinetics/pharmacodynamics, immunogenicity and anti-tumor activity of LAT010 in Chinese subjects with locally advanced or metastatic solid tumors
评估LAT010单药治疗在局部晚期或转移性实体瘤受试者中的安全性和耐受性。
[Translation] To evaluate the safety and tolerability of LAT010 monotherapy in subjects with locally advanced or metastatic solid tumors.